PATRICK F SMITH

CIK 1890360 · PRESIDENT, DRUG DEV SOLUTIONS · last filed 2024-10-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$407.2K

Companies

1

Total Filings

19

Lifetime Open-Market Net

-$1.28M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CERT PRESIDENT, DRUG DEV SOLUTIONS 50,091 $8.13 $407.2K -$1.28M 14 2024-10-08

Recent Filings · Page 2 of 2

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-06 CERT Sell (S) −19,104 -$411.7K EDGAR
2023-06-05 CERT Notice (144) −19,104 -$411.7K EDGAR
2023-04-03 CERT Mixed +4,220 -$105.3K EDGAR
2022-11-14 CERT Sell (S) −2,387 -$32.2K EDGAR
2022-11-02 CERT Tax (F) −1,244 -$15.2K EDGAR
2022-08-18 CERT Sell (S) −10,000 -$177.1K EDGAR
2022-06-09 CERT Sell (S) −10,000 -$191.6K EDGAR
2022-04-05 CERT Mixed −4,884 -$107.6K EDGAR
2021-11-01 CERT Grant (A) +3,631 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.